About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2678248
Allelic
Composition
Prkntm1Roo/Prkntm1Roo
Genetic
Background
either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkntm1Roo mutation (0 available); any Prkn mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• reduced amphetamine-induced motor activity

growth/size/body
• reduced body weight after weaning, both males and females

homeostasis/metabolism
• reduced rectal temperature relative to wild-type
• increased in the limbic brain areas
• increased levels of the MAO-derived metabolite, DOPAC, relative to COMT-derived metabolite, 3-MT, indicating an impairment of dopamine release

muscle
N
• no evidence of muscle degeneration

nervous system
N
• brain morphology, weight, and size were normal
• inhibition of dopamine neurotransmission
• inhibition of glutamate neurotransmission
• normal levels of 5-HT and 5-HIAA in the striatum, limbic system, diencephalon, and brainstem

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Parkinson's disease 2 DOID:0060368 OMIM:600116
J:85561


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/12/2024
MGI 6.23
The Jackson Laboratory